Electrical stimulation systems
Percept™ PC neurostimulator with BrainSense™ technology
<p>Percept™ PC neurostimulator with exclusive, adaptive BrainSense™ technology uses advanced programming capabilities for closed-loop DBS therapy.</p>
Features
BrainSense™ technology captures brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.* Clinicians can also correlate these brain signals with stimulation and patient-captured events such as medication, symptoms, or side effects.
Percept™ PC device is also designed to facilitate expanded capabilities in the future via software upgrades — so you’re prepared for what’s next in DBS.
Enhanced BrainSense™ survey
See electrode-level comparisons — between segmented levels, among segments within each level, and in each direction between the two levels.
Engineered for patient comfort
Ergonomically designed, the Percept™ PC device offers enhanced comfort for patients.
* In overall device volume.
† Refers to case thickness.
Percept™ PC neurostimulator with BrainSense™ technology
3T and 1.5T MR Conditional‡ DBS system with a directional, sensing lead.
Designed to last longer — and keep you informed
The Percept™ PC device offers improved longevity†† and features smart battery technology**
Simple.
Personal.
Smart
The DBS patient programmer is enhanced so patients can more easily and conveniently engage with their therapy.
Insight-Driven Technology
Inside or outside of the clinic
The Percept™ PC device features BrainSense™ technology*, designed to capture brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.
You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects — to deliver personalized, data-driven treatment and adjust as patient needs evolve.*
Percept™ PC neurostimulator and Sensight™ directional lead
The DBS system designed with sensing for better detection
- LFPs are 1 million times smaller than DBS stimulation pulses1
- Improved insulation for enhanced detection of LFPs with the Percept™ PC neurostimulator with BrainSense™ technology*
- The SenSight™ directional lead was developed with proprietary materials, components, and processes used to meet rigorous specifications designed for sensing.
Unlock your programming potential
OptiStim™ and ShapeLock™ controls along with multiple-rate features are enabled by the 16 independent current sources in the Percept™ PC device, giving you access to our wide range of programming options.
OptiStim™ control
OptiStim™ control allows you to assign unique amplitude values to each electrode. Add or subtract segments from the configuration without dropping amplitude of all electrodes to zero (in unipolar mode).
ShapeLock™ control
After achieving desired stimulation shape with OptiStim™ control, use ShapeLock™ control to seamlessly increase or decrease the shape created — an intuitive interface for advanced programming needs.
Multiple rates
Select a pair of rates and assign any electrode across the two leads to one of the two rates.
Assign different rates by electrode — to electrodes in different hemispheres or to different electrodes on the same lead.
Specifications
Compatible with:
- SenSight™ lead models B33005 and B33015
- Lead model 3387
- Lead model 3389
- Lead model 3391
- SenSight™ Extension model B34000
- Extension model 37086
- Clinician programmer CT900 (tablet) with clinican programmer software application A610, and communicator model 8880T2
- DBS patient programmer model TH91D with patient programmer software application A620
| Model | B35200 |
| Battery | Primary cell |
| Weight | 61 g |
| Height | 68 mm |
| Length | 51 mm |
| Channels | 2 |
Related links
† The sensing feature of the Percept™ PC system is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. The majority of patients with Parkinson’s disease have an identifiable signal. Signal may not be present or measurable in patients treated for essential tremor, dystonia, epilepsy, or obsessive-compulsive disorder. Humanitarian device: The effectiveness of these devices for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.
‡ As compared to Boston Scientific Vercise Genus P16. MP92328632-05 REV-A. As compared to Abbott Infinity 5/7. IPG. ARTEN600150429 - B.
§ For median energy use in DBS for patients with Parkinson’s disease.
◊ Based on current actual battery level and therapy settings from last seven days.
- Neumann WJ, Staub F, Horn A, et al. Deep brain recordings using an implanted pulse generator in Parkinson’s disease. Neuromodulation. 2016;19(1):20–24.